|
|
|||
| Cystic Fibrosis (CF) is an autosomal recessive genetic disorder characterized by chronic pulmonary disease, pancreatic insufficiency, and male infertility. The disease frequency is approximately one in 2,500 newborns, and the estimated carrier frequency in the Caucasian and Ashkenazi Jewish populations is approximately 1 in 25. This disorder is caused by mutations in two copies of the Cystic Fibrosis Transmembrane Regulator gene (CFTR). Most CFTR mutations can be identified through targeted CF mutation detection panels. For individuals who are negative for mutations by targeted mutation testing, DNA sequence analysis of the entire CFTR gene coding region is available at the Baylor Medical Genetics Laboratories. Reasons for Referral:
Testing Methodology:PCR amplification of 27 exons contained in the CFTR gene coding region will be performed on patient genomic DNA. Direct sequencing of amplification products is performed in both the forward and reverse directions using automated fluorescence dideoxy sequencing methods. Sensitivity:Analytical: ~99% Specimen Requirements:Blood for DNA:
EDTA (purple-top) tubes: Adults: 14
cc; Child/Infant: 6 cc Turnaround Time:4 weeks CPT Codes and Prices:
Index: 83891, 83898X29, 83894, 83904x58, 83909x58,
83912 Shipping InformationForms: >> Gene
Sequencing Requisition References:1. Strom CM, Huang D, Chen C, Buller A, Peng
M, Quan F, Redman J, Sun W (2003) Extensive sequencing of the cystic fibrosis
transmembrane regulator gene: assay validation and unexpected benefits
of developing a comprehensive test. Genet Med 2003.5: 9-14. Test Codes:Index: 6370 |